Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer

Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer

Mar 28, 2022

PHILADELPHIA–(BUSINESS WIRE)–┬áRenovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases, today announced the appointment of Fred Driscoll as Chief Financial Officer (CFO).